Consulting Services For The Definition Of The Strategy And If Appropriate Implementation Of The Veiasa Erp In Business Central Including The Reimplementation And Selective Migration Of Data Processes And Integrations

Deadline: 12 Jun 2027

Spain

Ref. No.: 28818517

EMD:Ref Document

Bid Value: Ref Document

211 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Ustekinumab Atc Code L04Ac05

Deadline: 27 May 2028

Germany

Ref. No.: 28818077

EMD:Ref Document

Bid Value: Ref Document

561 Days Left

Open House Drug Discount Agreements Macrogol Only Products That Can Be Prescribed According To Appendix 1 Am Rl G Ba Or Medical Products That Can Be Prescribed According To Appendix 5 Am Rl G Ba Atc A06Ad15

Deadline: 03 Jun 2028

Germany

Ref. No.: 28817920

EMD:Ref Document

Bid Value: Ref Document

568 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Naloxegol Atc A06Ah03 For The Period August 1St 2026 July 31St 2028

Deadline: 05 Jun 2028

Germany

Ref. No.: 28817773

EMD:Ref Document

Bid Value: Ref Document

570 Days Left

Basic Monitoring Of Environmental Toxins In Fresh Water Milfersk 2027 2031

Deadline: 13 Nov 2026

Norway

Ref. No.: 28817272

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Occupational Health

Deadline: 31 Dec 2032

Finland

Ref. No.: 28817114

EMD:Ref Document

Bid Value: Ref Document

2240 Days Left

Open House Drug Discount Agreements Dolutegravir And Rilpivirine Atc J05Ar21

Deadline: 03 Jun 2028

Germany

Ref. No.: 28814487

EMD:Ref Document

Bid Value: Ref Document

568 Days Left

Dynamic Procurement System For Charging Infrastructure

Deadline: 31 Dec 2036

Denmark

Ref. No.: 28814361

EMD:Ref Document

Bid Value: Ref Document

3701 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Colistin Atc J01Xb01 For The Period August 1St 2026 July 31St 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2029

Germany

Ref. No.: 28813502

EMD:Ref Document

Bid Value: Ref Document

935 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Omalizumab Atc L04Ag08 For The Period August 1St 2026 July 31St 2028

Deadline: 05 Jun 2028

Germany

Ref. No.: 28812681

EMD:Ref Document

Bid Value: Ref Document

570 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Fesoterodine Atc G04Bd11 For The Period August 1St 2026 July 31St 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2029

Germany

Ref. No.: 28812647

EMD:Ref Document

Bid Value: Ref Document

935 Days Left

Open House Drug Discount Agreements Bimatoprost Atc S01Ee03

Deadline: 03 Jun 2028

Germany

Ref. No.: 28812493

EMD:Ref Document

Bid Value: Ref Document

568 Days Left

Open House Drug Discount Agreements Interferon Beta 1A Finished Drug Name Rebif R Atc L03Ab07

Deadline: 03 Jun 2028

Germany

Ref. No.: 28811169

EMD:Ref Document

Bid Value: Ref Document

568 Days Left

Dynamic Purchasing System It Consulting Services

Deadline: 12 May 2036

Sweden

Ref. No.: 28810532

EMD:Ref Document

Bid Value: Ref Document

3468 Days Left

Medicines With The Active Ingredient Guselkumab Atc L04Ac16

Deadline: 31 May 2028

Germany

Ref. No.: 28806740

EMD:Ref Document

Bid Value: Ref Document

565 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!